RPRX

NASDAQ · Pharmaceuticals

Royalty Pharma Plc- Cl A

Large-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks

$44.65

+0.55 (+1.25%)

As of Feb 21, 12:10 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target -18.8% upside

Low Target $26.65

Average Target $36.26

High Target $40.53

Current Price $44.65

Current
$44.65

Target
$36.26

$26.65 $36.26 avg $40.53

Scenario Analysis

Bear Case

$26.65

-40.3%

Low target

Base Case

$36.26

-18.8%

Avg target

Bull Case

$40.53

+-9.2%

High target

Risk/Reward

0.2x

Unfavorable

Price in Context

52-Week High

$46.14

-3.2% from high

52-Week Low

$29.66

+50.5% from low

50-Day SMA

$40.77

+9.5% vs SMA

200-Day SMA

$37.28

+19.8% vs SMA

RSI (14)

85.1

Overbought

Target vs 52W High

$36.26

-21.4% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Buy	37	73%	$1,330.33	+25.7%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+21.8%
MRK Merck & Co. Inc.	Buy	34	62%	$159.27	+28.6%
PFE Pfizer Inc.	Hold	33	45%	$33.90	+25.3%
BMY Bristol-Myers Squibb Co	Hold	34	41%	$174.50	+184.9%
ZTS Zoetis Inc	Buy	24	67%	$209.87	+65.4%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	14	93%	$36.26	-18.8%
VTRS Viatris Inc	Buy	18	61%	$122.82	+670.0%